These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27103882)

  • 1. Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy.
    Angeloni E
    Core Evid; 2016; 11():1-10. PubMed ID: 27103882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azilsartan medoxomil: a new Angiotensin receptor blocker.
    Zaiken K; Cheng JW
    Clin Ther; 2011 Nov; 33(11):1577-89. PubMed ID: 22071238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive.
    Pierini D; Anderson KV
    Ann Pharmacother; 2013 May; 47(5):694-703. PubMed ID: 23585646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azilsartan/chlorthalidone combination therapy for blood pressure control.
    Cheng JW
    Integr Blood Press Control; 2013; 6():39-48. PubMed ID: 23807859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
    White WB; Weber MA; Sica D; Bakris GL; Perez A; Cao C; Kupfer S
    Hypertension; 2011 Mar; 57(3):413-20. PubMed ID: 21282560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension.
    Baker WL; White WB
    Ann Pharmacother; 2011 Dec; 45(12):1506-15. PubMed ID: 22116996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2013 Nov; 14(16):2249-61. PubMed ID: 24070321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of azilsartan medoxomil with chlorthalidone in hypertension.
    Baker WL; Nigro SC; White WB
    Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):791-8. PubMed ID: 24881461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review.
    Katsi V; Michalakeas C; Soulaidopoulos S; Antonopoulos AS; Vlachopoulos C; Tousoulis D; Tsioufis K
    Curr Hypertens Rev; 2021; 17(3):217-227. PubMed ID: 33438552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
    Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients.
    Rakugi H; Shimizu K; Sano Y; Nishiyama Y; Kinugawa Y; Terashio S
    Blood Press Monit; 2018 Apr; 23(2):91-102. PubMed ID: 29239867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis.
    Kumar L; Khuwaja S; Kumar A; Memon UA; Kumar M; Ashok A; Lohana M; Qudoos A; Kashif M; Khatri M; Kumar S; Sapna F; Dass A; Varrassi G
    Cureus; 2023 Jun; 15(6):e41198. PubMed ID: 37525792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone.
    Weber MA; Sever P; Juhasz A; Roberts A; Cao C
    J Renin Angiotensin Aldosterone Syst; 2018; 19(3):1470320318795000. PubMed ID: 30175930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hronotherapy Aspects of Efficiency Azilsartan Medoxomil in Combination Therapy in Patients With Hypertension and Metabolic Syndrome].
    Skibitskiy VV; Fendrikova AV; Sirotenko DV; Skibitskiy AV
    Kardiologiia; 2016 Oct; 56(10):35-40. PubMed ID: 28290893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed-Dose Combination in Healthy Adults.
    Dudkowski C; Karim A; Munsaka M
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):393-8. PubMed ID: 27514506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: the ACS1 Study.
    Kario K; Hoshide S
    Hypertension; 2015 Apr; 65(4):729-35. PubMed ID: 25646296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive Efficacy of Fixed Combination Azilsartan Medoxomil / Chlorthalidone in Patients With Uncontrolled Arterial Hypertension].
    Kobalava ZD; Villevalde SV; Kulakov VV
    Kardiologiia; 2017 Nov; 57(11):12-18. PubMed ID: 29276912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG; Marbury TC; Robinson TD
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.